Skip to content

TYRA BIOSCIENCES, INC.

US · TYRA #3032 by market cap Listed 2021
20.12 +0.39 +1.98%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 5 in the most recent period (2026/Q3).
  • Total institutional ownership fell 2.7 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
114.70% -2.68pp
Institutions
202 -5
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund46.46%
VC/PE Fund40.83%
Hedge Fund24.13%
Individual/Insider2.27%
Public Company1.89%
Private Company0.62%
Sovereign Wealth Fund0.25%
Government Pension Fund0.20%
Endowment Fund0.18%
Insurance Company0.11%

Top holders as of 2026-09-15

RA Capital Management, L.P. 17.66% · 12.20M sh
FMR 15.25% · 10.54M sh
Janus Henderson Group plc 6.30% · 4.35M sh
BVF Partners L.P. 6.10% · 4.22M sh
Alta Partners LP 5.53% · 3.82M sh
Nextech Invest Ltd. 5.14% · 3.55M sh
Paradigm Biocapital Advisors LP 5.03% · 3.47M sh
Artal Group S.A. 4.92% · 3.40M sh
BlackRock 4.78% · 3.30M sh
T. Rowe Price Group, Inc. 4.05% · 2.78M sh
TCG Crossover Management, LLC 4.70% · 3.25M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 31 buys · 18 sells

NameRoleStake
RA Capital Management, L.P. -- 17.66%
Todd Harris Chief Executive Officer 1.97%
Daniel Bensen Co-Founder & Chief Discovery Officer 0.21%
Gilla Kaplan Former Independent Director 0.04%
Alan Fuhrman Chief Financial Officer 0.02%
Julia Rueb VP of Finance & Principal Accounting Officer 0.02%
Adele M. Gulfo Independent Director 0.01%
Rehan Verjee Independent Director 0.00%
Alta Partners LP -- --
Canaan Management, Inc. -- --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-14 Alan Fuhrman Chief Financial Officer Other Acquisition +951 $9.13
2026-09-14 RA Capital Management, L.P. -- Open Market Derivative Acquisiti +9,078,529 $0.00
2026-09-14 Todd Harris Chief Executive Officer Other Acquisition +864 $9.13
2026-09-14 Julia Rueb VP of Finance & Principal Accounting Officer Other Acquisition +2,925 $9.13
2026-09-08 Rehan Verjee Independent Director Open Market Acquisition +971 $20.58
2026-05-27 Robert J. More Independent Director Other Derivative Acquisition +13,160 $32.68
2026-05-27 RA Capital Management, L.P. -- Other Derivative Acquisition +13,160 $32.68
2026-05-27 Adele M. Gulfo Independent Director Other Derivative Acquisition +13,160 $32.68
2026-05-27 Rehan Verjee Independent Director Other Derivative Acquisition +13,160 $32.68
2026-05-27 S. Rothenberg Independent Director Other Derivative Acquisition +13,160 $32.68
2026-05-27 Jake Simson Independent Director Other Derivative Acquisition +13,160 $32.68
2026-05-27 Susan Moran Independent Director Other Derivative Acquisition +13,160 $32.68
2026-05-04 Alan Fuhrman Chief Financial Officer Other Acquisition +20,000 --
2026-05-04 Alan Fuhrman Chief Financial Officer Other Derivative Acquisition +67,000 $33.93
2026-05-04 Todd Harris Chief Executive Officer Other Acquisition +79,000 --
2026-05-04 Todd Harris Chief Executive Officer Other Derivative Acquisition +265,000 $33.93
2026-05-04 Bhavesh Ashar Chief Operating Officer Other Acquisition +15,013 --
2026-05-04 Bhavesh Ashar Chief Operating Officer Other Derivative Acquisition +50,295 $33.93
2026-05-04 Douglas Warner Chief Medical Officer Other Acquisition +25,000 --
2026-05-04 Douglas Warner Chief Medical Officer Other Derivative Acquisition +85,000 $33.93

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

TYRA BIOSCIENCES, INC. discussion 0 comments

Add a comment